PYCR1 and hepatocellular carcinoma: In hepatocellular cancer cells, shRNA-mediated knockdown of PYCR1 in vitro resulted in significantly decreased activation of the stress-activated protein kinase/c-Jun NH(2)-terminal kinase (SAPK/JNK) signaling pathway and the insulin receptor substrate 1102.